GABA Receptor Agonists Protect From Excitotoxic Damage Induced by AMPA in Oligodendrocytes
Open Access
- 26 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 897056
Abstract
Oligodendrocytes are the myelin forming cells of the central nervous system, and their vulnerability to excitotoxicity induced by glutamate contributes to the pathogenesis of neurological disorders including brain ischemia and neurodegenerative diseases, such as multiple sclerosis. In addition to glutamate receptors, oligodendrocytes express GABA receptors (GABAR) that are involved in their survival and differentiation. The interactions between glutamate and GABAergic systems are well documented in neurons, under both physiological and pathological conditions, but this potential crosstalk in oligodendrocytes has not been studied in depth. Here, we evaluated the protective effect of GABAR agonists, baclofen (GABAB) and muscimol (GABAA), against AMPA-induced excitotoxicity in cultured rat oligodendrocytes. First, we observed that both baclofen and muscimol reduced cell death and caspase-3 activation after AMPA insult, proving their oligoprotective potential. Interestingly, analysis of the cell-surface expression of calcium-impermeable GluR2 subunits in oligodendrocytes revealed that GABAergic agonists significantly reverted GluR2 internalization induced by AMPA. We determined that baclofen and muscimol also impaired AMPA-induced intracellular calcium increase and subsequent mitochondrial membrane potential alteration, ROS generation, and calpain activation. However, AMPA-triggered activation of Src, Akt, JNK and CREB was not affected by baclofen or muscimol. Overall, our results suggest that GABAR activation initiates alternative molecular mechanisms that attenuate AMPA-mediated apoptotic excitotoxicity in oligodendrocytes by interfering with expression of GluR subunits in membranes and with calcium-dependent intracellular signaling pathways. Together, these findings provide evidence of GABAR agonists as potential oligodendroglial protectants in central nervous system disorders.Keywords
Funding Information
- Euskal Herriko Unibertsitatea
This publication has 54 references indexed in Scilit:
- Roles of White Matter in Central Nervous System PathophysiologiesASN Neuro, 2012
- GABABReceptor Activation Protects Neurons from Apoptosis via IGF-1 Receptor TransactivationThe Journal of Neuroscience, 2010
- Mitochondrial membrane permeabilization in neuronal injuryNature Reviews Neuroscience, 2009
- Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2008
- Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matterNature Neuroscience, 2008
- Excitotoxic damage to white matterJournal of Anatomy, 2007
- NMDA receptors mediate calcium accumulation in myelin during chemical ischaemiaNature, 2005
- AMPA RECEPTOR REGULATION MECHANISMS: FUTURE TARGET FOR SAFER NEUROPROTECTIVE DRUGSInternational Journal of Neuroscience, 2004
- Mitochondria and calcium: from cell signalling to cell deathThe Journal of Physiology, 2000
- AMPA and Kainate Receptors Each Mediate Excitotoxicity in Oligodendroglial CulturesNeurobiology of Disease, 1999